Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04253418 · ClinicalTrials.gov registry record · NA
Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization Study
A NA study, sponsored by Pulse Biosciences.
- Terminated
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT04253418 is a NA study that was terminated before completion, run by Pulse Biosciences. The registered enrollment target is 125 participants.
The verdict
NCT04253418, a NA study, was terminated before completion, sponsored by Pulse Biosciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
Primary study objective is to evaluate the optimization of Nano-Pulse Stimulation (NPS) energy settings for lesion clearance of Sebaceous Hyperplasia (SH) lesions from facial areas of healthy adult subjects.
Interventions
- DEVICE Nano-Pulse Stimulation (NPS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2018-12-20 |
| Est. Completion | 2021-03-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04253418
The ClinicalTrials.gov registry entry for NCT04253418 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pulse Biosciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nano-Pulse Stimulation (NPS) is the first listed.
NCT04253418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04253418 about?
NCT04253418 is a clinical study titled "Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization Study". Primary study objective is to evaluate the optimization of Nano-Pulse Stimulation (NPS) energy settings for lesion clearance of Sebaceous Hyperplasia (SH) lesions from facial areas of healthy adult subjects.
What is the current status of trial NCT04253418?
This trial is currently terminated. It is a NA study. The enrollment target is 125 participants. The study started on 2018-12-20. Estimated completion is 2021-03-26.
What interventions are being tested in trial NCT04253418?
The interventions under investigation include: Nano-Pulse Stimulation (NPS) (DEVICE).
Who is sponsoring clinical trial NCT04253418?
This trial is sponsored by Pulse Biosciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.